Close Menu

NEW YORK – NeoGenomics today reported a 50 percent year-over-year uptick in its second quarter revenues with strong growth in both its clinical services and pharma services businesses.

For the three months ended June 30, total revenues reached $101.7 million, up from $67.7 million in Q2 2018, and beating analysts' average estimate of $97.3 million.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Researchers uncovered the HIV virus within a tissue sample collected in 1966, the Atlantic reports.

Nature News reports there are a handful of clinical trials underway to evaluate vaginal microbiome seeding of newborns born via caesarian section.

The Washington Post writes that humans may have contributed to the extinction of cave bears some 20,000 years ago.

In PLOS this week: gene variant may protect against trypanosomiasis, GLIS3 role in type 2 diabetes, and more.